Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ANUH PHARMA vs SUVEN LIFE SCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ANUH PHARMA SUVEN LIFE SCIENCES ANUH PHARMA/
SUVEN LIFE SCIENCES
 
P/E (TTM) x 22.7 -20.5 - View Chart
P/BV x 5.1 5.8 88.1% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 ANUH PHARMA   SUVEN LIFE SCIENCES
EQUITY SHARE DATA
    ANUH PHARMA
Mar-23
SUVEN LIFE SCIENCES
Mar-23
ANUH PHARMA/
SUVEN LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs11094 117.2%   
Low Rs7745 171.1%   
Sales per share (Unadj.) Rs105.30.6 16,954.9%  
Earnings per share (Unadj.) Rs7.2-5.4 -133.1%  
Cash flow per share (Unadj.) Rs9.2-5.1 -178.7%  
Dividends per share (Unadj.) Rs2.000-  
Avg Dividend yield %2.10-  
Book value per share (Unadj.) Rs48.117.2 279.7%  
Shares outstanding (eoy) m50.11218.07 23.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.9111.8 0.8%   
Avg P/E ratio x12.9-12.8 -101.2%  
P/CF ratio (eoy) x10.2-13.5 -75.4%  
Price / Book Value ratio x1.94.0 48.2%  
Dividend payout %27.70-   
Avg Mkt Cap Rs m4,68315,131 30.9%   
No. of employees `000NANA-   
Total wages/salary Rs m172186 92.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m5,275135 3,896.0%  
Other income Rs m6184 72.4%   
Total revenues Rs m5,336220 2,426.8%   
Gross profit Rs m518-1,196 -43.3%  
Depreciation Rs m9765 148.3%   
Interest Rs m75 138.7%   
Profit before tax Rs m475-1,183 -40.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1130-   
Profit after tax Rs m362-1,183 -30.6%  
Gross profit margin %9.8-883.6 -1.1%  
Effective tax rate %23.80-   
Net profit margin %6.9-873.5 -0.8%  
BALANCE SHEET DATA
Current assets Rs m3,0763,455 89.0%   
Current liabilities Rs m1,6131,050 153.6%   
Net working cap to sales %27.71,776.0 1.6%  
Current ratio x1.93.3 58.0%  
Inventory Days Days663,948 1.7%  
Debtors Days Days1,185218 544.3%  
Net fixed assets Rs m9661,373 70.3%   
Share capital Rs m251218 114.9%   
"Free" reserves Rs m2,1623,535 61.1%   
Net worth Rs m2,4123,753 64.3%   
Long term debt Rs m00-   
Total assets Rs m4,0424,828 83.7%  
Interest coverage x64.6-218.8 -29.5%   
Debt to equity ratio x00-  
Sales to assets ratio x1.30 4,653.6%   
Return on assets %9.1-24.4 -37.5%  
Return on equity %15.0-31.5 -47.6%  
Return on capital %20.0-31.4 -63.7%  
Exports to sales %52.540.4 129.8%   
Imports to sales %53.2839.8 6.3%   
Exports (fob) Rs m2,77055 5,058.6%   
Imports (cif) Rs m2,8081,137 246.9%   
Fx inflow Rs m2,77055 5,058.6%   
Fx outflow Rs m2,8081,137 246.9%   
Net fx Rs m-38-1,082 3.5%   
CASH FLOW
From Operations Rs m539-1,031 -52.3%  
From Investments Rs m-435-2,606 16.7%  
From Financial Activity Rs m-1233,955 -3.1%  
Net Cashflow Rs m-19317 -5.9%  

Share Holding

Indian Promoters % 69.9 69.6 100.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.6 -  
FIIs % 0.0 0.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 30.1 30.4 98.8%  
Shareholders   20,520 74,003 27.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ANUH PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ANUH PHARMA vs Suven Life Sciences

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ANUH PHARMA vs Suven Life Sciences Share Price Performance

Period ANUH PHARMA Suven Life Sciences S&P BSE HEALTHCARE
1-Day -1.48% 0.30% 1.18%
1-Month 17.85% -2.06% -0.75%
1-Year 210.26% 114.92% 61.82%
3-Year CAGR 38.85% 14.94% 18.16%
5-Year CAGR 29.47% -16.22% 19.79%

* Compound Annual Growth Rate

Here are more details on the ANUH PHARMA share price and the Suven Life Sciences share price.

Moving on to shareholding structures...

The promoters of ANUH PHARMA hold a 69.9% stake in the company. In case of Suven Life Sciences the stake stands at 69.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ANUH PHARMA and the shareholding pattern of Suven Life Sciences.

Finally, a word on dividends...

In the most recent financial year, ANUH PHARMA paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 27.7%.

Suven Life Sciences paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of ANUH PHARMA, and the dividend history of Suven Life Sciences.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.